GHK-Cu: dosing evidence
Human schedule
As an injectable reagent, GHK-Cu is used subcutaneously (SC), typically into soft abdominal tissue. The values below are generalized from described protocols and studies.
This is a concise reference to regimens described for adults; it is not an individual prescription.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start (≈first 2 weeks) | 1 mg subcutaneously daily, ~5 days/week | Starting dose |
| Later within the cycle | 2 mg subcutaneously daily | Increase if needed |
| Body-weight reference | 15–30 mcg/kg daily | Maximum in this schedule |